Skip to main content
. 2023 May 10;2023(5):CD014682. doi: 10.1002/14651858.CD014682.pub2

Shabbir 2011.

Methods Parallel, 3‐arm RCT
Participants Patients with peripheral diabetic neuropathy for at least 6 months duration, an average pain score ≥ 4 (on an 11‐point, Likert‐like NRS; 0 = “no pain” to 10 = “worst possible pain”) over a 7‐day baseline period
Interventions Amitriptyline
Pregabalin
Placebo
Flexibly dosed depending upon tolerance
Outcomes Pain intensity
50% pain relief
Notes Unable to ascertain blinding